TRI-E® PREVENTS COGNITIVE IMPAIRMENT AND DEOXYRIBONUCLEIC ACID DAMAGE IN DIABETES MELLITUS
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i9.20435Keywords:
Diabetes, Deoxyribonucleic acid damage, Cognitive decline, Comet assay, TocotrienolAbstract
Â
 Objective: The aim of the current study is to compare the difference of Tri-E® and ATF potentials in reducing diabetic adverse event due to hyperglycemia that might cause the DNA damage and cognitive impairment indirectly.
Methods: Diabetic model sample from Sprague Dawley was developed by combination of twice low-dose streptozotocin injection and high fat diet. The diabetic rat model was treated with Tri-E® and ATF in different groups, control group were provided. The DNA was collected from the whole blood and DNA damage was measured using the comet assay method. While cognitive status was measured using Morris water-maze method.
Result: Reduction of the DNA damage and improvement of cognitive function were observed in both ATF and Tri-E® supplementations that elevated in diabetic. However, the DNA damage reduction by Tri-E® was one-fold higher compared to ATF supplementation.
Conclusion: This study provided data that Tri-E® has superior potential than ATF as a preventative agent to DNA damage and cognitive impairment in diabetes indirectly.
Downloads
References
Satish CS. Formulation and evaluation of a chitosan-PVA-gellan insulin implant. Int J Appl Pharm 2017;9(3):37-41.
Khatri SK, Rathnanand M, Nikhila R. Formulation and evaluation of wound healing activity of linezolid topical preparations on diabetic rats. Int J Appl Pharm 2016;8(3):30-6.
Kant R, Bodla R, Kapoor G, Bhutani R. Development and validation of novel spectrophotometric methods for simultaneous estimation of pioglitazone and metformin in bulk and fixed dosage forms by area under curve and dual wave-length mode. Int J Appl Pharm 2016;8(3):48-53.
Rupeshkumar M, Kavitha K, Haldar PK. Role of herbal plants in the diabetes mellitus therapy: An overview. Int J Appl Pharm 2014;6(3):1-3.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53.
Stalin C, Dineshkumar P, Nithiyananthan K. Evaluation of antidiabetic activity of methanolic leaf extract of Ficus carica in alloxan - Induced diabetic rats. Asian J Pharm Clin Res 2012;5(3):85-7.
Malini P, Kanchana G, Rajadurai M. antidiabetic efficacy of ellagic acid in streptozotocininduced diabetes mellitus in Albino Wistar rats. Asian J Pharm Clin Res 2011;4(3):1248.
Mushtaq S, Mayee KR, Amreen S, Satyanarayana V, Yerramilli A, Ramakrishnan S. A study on the current prescribing patterns of dipeptidyl peptidase 4 Inhibitors in a multi speciality hospital outpatient setting. Asian J Pharm Clin Res 2014;7(2):134-6.
International Diabetes Federation. IDF Diabetes Atlas. 7th ed. 2015. Available from: http://www.oedg.at/pdf/1606_IDF_Atlas_2015_UK.pdf. [Last accessed on 2017 Jun 01.
Letchuman GR, Nazaimoon WM, Mohamad WB, Chandran LR, Tee GH, Jamaiyah H, et al. Prevalence of diabetes in the Malaysian national health morbidity survey III 2006: The Malaysian national health morbidity survey III (NHMS). Med J Malays 2010;65(3):173-9.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87(1):4-14.
Qureshi AA, Reis JC, Papasian CJ, Morrison DC, Qureshi N. Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice. Lipids Health Dis 2010;9:143.
Larsson HE, Vehik K, Bell R, Dabelea D, Dolan L, Pihoker C, et al. Reduced prevalence of diabetic ketoacidosis at diagnosis of Type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 2011;34:2347-52.
Vassy JL, Durant NH, Kabagambe EK, Carnethon MR, Rasmussen-Torvik LJ, Fornage M, et al. A genotype risk score predicts Type 2 diabetes from young adulthood: The CARDIA study. Diabetologia 2012;55:2604-12.
Tuzcu M, Baydas G. Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur J Pharmacol 2006;537(1-3):106-10.
Lange ML, Cenini G, Piroddi M, Mohmmad-Abdul H, Sultana R, Galli F, et al. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease. Neurobiol Dis 2008;29:456-64.
Debling D, Amelang M, Hasselbach P, Stürmer T. Diabetes and cognitive function in a population-based study of elderly women and men. J Diabetes Complications 2006;20(4):238-45.
Pazdro R, Burgess JR. The role of vitamin E and oxidative stress in diabetes complications. Mech Ageing Dev 2010;131(4):276-86.
Comin D, Gazarini L, Zanoni JN, Milani H, de Oliveira RM. Vitamin E improves learning performance and changes the expression of nitric oxide-producing neurons in the brains of diabetic rats. Behav Brain Res 2010;210(1):38-45.
Mangialasche F, Xu W, Kivipelto M, Costanzi E, Ercolani S, Pigliautile M, et al. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging 2012;33:2282-90.
Salinthone S, Kerns AR, Tsang V, Carr DW. A-Tocopherol (vitamin E) stimulates cyclic AMP production in human peripheral mononuclear cells and alters immune function. Mol Immunol 2013;53(3):173-8.
Ng LT, Ko HJ. Comparative effects of tocotrienol-rich fraction, a-tocopherol and a-tocopheryl acetate on inflammatory mediators and nuclear factor kappa B expression in mouse peritoneal macrophages. Food Chem 2012;134(2):920-5.
Budin SB, Othman F, Louis SR, Bakar MA, Das S, Mohamed J. The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats. Clinics (Sao Paulo) 2009;64(3):235-44.
Chin SF, Hamid NA, Latiff AA, Zakaria Z, Mazlan M, Yusof YA, et al. Reduction of DNA damage in older healthy adults by Tri E Tocotrienol supplementation. Nutrition 2008;24(1):1-10.
Chin SF, Ibahim J, Makpol S, Abdul Hamid NA, Abdul Latiff A, Zakaria Z, et al. Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study. Nutr Metab (Lond) 2011;8(1):42.
Zhang M, Lv XY, Li J, Xu ZG, Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced Type 2 diabetes rat model. Exp Diabetes Res 2008;2008:704045.
Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for Type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52(4):313-20.
Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58(3):397-405.
D’Hooge R, De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 2001;36(1):60-90.
Heaton PR, Ransley R, Charlton CJ, Mann SJ, Stevenson J, Smith BH, et al. Application of single-cell gel electrophoresis (comet) assay for assessing levels of DNA damage in canine and feline leukocytes. J Nutr 2002;132:1598S-603.
Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and Type 2 diabetes in Asia. Lancet 2006;368:1681-8.
Biessels GJ. Cerebral complications of diabetes: Clinical findings and pathogenetic mechanisms. Neth J Med 1999;54:35-45.
Jialal I, Devaraj S, Venugopal SK. Oxidative stress, inflammation, and diabetic vasculopathies: The role of alpha tocopherol therapy. Free Radic Res 2002;36:1331-6.
Barbieri M, Boccardi V, Paolisso G. Diet and Nutrition in Dementia and Cognitive Decline. Naploy, Italy: Elsevier Inc.; 2015. p. 393-402.
Dahlan HM, Karsani SA, Rahman MA, Hamid NA, Top AG, Ngah WZ. Proteomic analysis reveals that treatment with tocotrienols reverses the effect of H2O2 exposure on peroxiredoxin expression in human lymphocytes from young and old individuals. J Nutr Biochem 2012;23:741-51.
Napoli Z, Seghieri G, Bianchi L, Anichini R, de Bellis A, Campesi I, et al. Taurine transporter gene expression in mononuclear blood cells of Type 1 diabetes patients. J Diabetes Res 2016;2016:1-7.
Tiwari V, Kuhad A, Bishnoi M, Chopra K. Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacol Biochem Behav 2009;93(2):183-9.
Kuhad A, Bishnoi M, Tiwari V, Chopra K. Suppression of NF-κβ signaling pathway by tocotrienol can prevent diabetes associated cognitive deficit. Pharmacol Biochem Behav 2009;92:251-9.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
